Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They really need to get a phase 1 trial going for intravenous use of TLD 1433. Just think how much easier it would be to treat patients and all the types of cancer that could be treated. Start an IV. Dose the TLD 1433. Wait the appropriate time. Use xray and/or laser to activate the TLD 1433. Then use "right to try" to start making a difference in patients lives. IMO.
LOL..... actually no. Just kidding. I was fortunate enough to get out of EPGL before the conversion. There were some folks that sunk some big time money into EPGL. I wonder if they were able to get out?
LOL.....bbbbbbbut there is always a chance of recovery with inwith(out).
Is anyone buying on the dips especially since it's tax loss season? I was thinking about picking up a few 100 thousand more shares. Maybe a million. I don't know.
Maybe it's time to start treating GBM off shore. Perseus is doing it with immunotherapeutics.
https://scbiznews.com/news/government/44688/
Regulatory approval
Dr. Robert M. Sade, director of the Institute of Human Values in Health Care and professor of surgery at the Medical University of South Carolina, said “there are ethics questions involved.” Those questions, he said, should be directed as much to the FDA as to any medical company taking the medical care offshore.
“The FDA has produced a system that retards the introduction of effective new treatments,” Sade said. “It takes a billion dollars and 10 years to put a new product on the market because of the demands of the FDA for multiple studies, for all kinds of information that I believe is largely unnecessary.”
He said physicians who are involved in providing such offshore medical treatments are “ethically bound not to use treatments that have no basis in science. There are people who take treatments offshore because they are quacks.”
Sade said “if there is scientific evidence the treatment is effective but still hasn’t been approved by the FDA, it would not be unethical to take it offshore.”
The original “gift” shares as promised really didn’t happen I guess. It was based only on the end amount of shares one had so anyone smart enough to sell didn’t get much of a “gift.” Tough titty I guess. Doooosh bags they are I guess. Oh well. Live and learn. Anyone interested in buying InWith shares for $50 or $65 a share? I didn’t think so. Well maybe in a few years? No? Cmon? Laser beam contact lens for sale. Get them here. Cheap and on sale. Lol. Not. All imo.
Dude. You were right!!!
Where do we go from here?
Well............tough titty.
Now InWith can do whatever they want. Perhaps their website can give you more info? Lol. They will have an exchange where shares can easily be bought and sold I’m sure. Lol. Lots of new “developments” coming too right? Don’t worry. In a few years (or decades) you will know more. Keep the faith. Remember they have a relationship with gmbr or gar or gab or some lawyer group in the great state of kalifornia right? Your investment is secure. Do not worry. High end folks involved. Gambini slovaki Campbell and Ross. Your money is secure. Guaranteed right?? Lol. We are phuked right? I’m glad I only own $500 worth.
Where is that prototype?
I feel bad for the folks with ten or even.....a hundred THOUSAND dollars in this. Night night. Ouch.
You’re right. Hoping the phase 2 trial is positive. Hopefully they start the phase 1 GBM trial soon.
So is theralase undervalued?
You are absolutely correct. i had my days mixed up. sorry about that.
The Theralase Annual Meeting is this afternoon. Wonder what will come out of it? Seems like some really good potential here.
Agree. What is encouraging to me is that humans have been treated with regard to bladder cancer and TLT's PDT did well. It's shouldn't be too long before trials start on humans with GBM as there is nothing out there now that does well to treat it. It's all encouraging IMO.
If the animal studies translate to human studies and can be used for multiple types of cancer (without the side effects of chemo/radiation/immunotherapy) the surely this company will be worth billions IMO. The success rate of treating different types of cancers is relatively low in most cases with current modalities and they are very expensive and have side effects....IMO
So TLT is a little over 30 cents now. Where do you see the share price moving to? Seems like this technology could be used for multiple types of cancer. Is this a potential billion dollar company? 10B? More?
This is amazing considering that only 2% of the patients with gliobastomas survive 3 years. Plus the side effects of chemo and radiation and the invasiveness of surgery seem to make PDT a much better option....at least in rats. They should start the studies on people asap IMO.
If thats the case they better be watching their back. Seems like there are some unhappy shareholders. I have a piddly few so I could care less. There are folks that will lose a lot I think. I feel bad for them. InWith $50/share. Yeah go etc. Unbelievable imo. Maybe smartlensconference 2018 in Las Vegas will clear this all up. Lol.
Lol. Ok. Right. Yep. That’s it. You got it. Buy out. Uh huh. Thank you.
Interesting. Senate Bill 206 passed and now President Trump can sign it. Perhaps Sen. McCain could benefit from treatment?
Thank you. I wonder how this will all play out considering that post.
Nope. Is it necessary or required? When they set up the eventual share exchange forum will it be necessary for the seeker to make sure the buyer is accredited? Thanks.
Yep. And did you know inwith is worth $50/share? Who will be the first to buy shares at this price? Who will be the first to be able to get $50 for a share? I think I’ll go to the trading exchange that was to be set up mid March and find out. Anyone have the link?
Wasn't March the end of the 1st quarter? Plus InWith has been around for over a year.......but nothing yet? Maybe we see something in July? Somehow have to fund that prototype. I wonder where it is being put together? Be nice to have an update on that. Only 7 months left in this year. Time is a flyin'.
Interesting.
Now InWith wouldn't dilute would they? They said they wouldn't dilute PEGL....I mean EPGL and they held true to their word right? How much does it cost to do an IPO? I'm sure InWith will show quarterly and yearly financials that will show enough money to cover the cost. Plus they have WSGR on their side and even took an equity position so that should give them billions in reserves right? $50/share....better scarf em' up soon. They'll be gone fast. Yep er ee. IMO. uh huh. right.
I wonder what "as soon as possible" means? A week? A month? Months? A year? Two years? A decade?
Maybe there could be a new company formed that would "buy" inwith and would give inwith shareholders more equity and then lower the A/S even more and announce a new management team and the initial share price could be $200/share and there would be a buy and sell exchange created? With a prototype built and an nyse billion dollar company hanging around? WSGR could "take an equity position" in that one too? Maybe?
A new tweet! A new tweet! No mention of the share sell/purchase exchange website thing though. Maybe tomorrow?
InWith Corporation
@InWithCorp
4m4 minutes ago
Welcome new $InWith shareholders! You are now part of an exclusive club of people who are the FIRST to own $InWith stock. Our company goal is IPO on NASDAQ or NYSE as soon as possible. Your broker and Broadridge are working to deliver your new shares + bonus equity.
WELCOME!
0 replies 1 retweet 2 likes
I wonder how long it will take for someone, anyone, to buy an InWith share at $50/share? A week? A month? A few months? A year? Two? A decade? Never? At the end of PEGL trading....I mean EPGL.... it didn't seem like there was much interest. Oh well.
Unless what?
"our shares will be in street names"
More like “our shares will be in the gutter of the street”
Thanks. I’ll do some more DD.
Any thoughts as far as dilution goes?
Maybe now is the time to buy those Sept calls?
Why are defense stocks getting hit so bad the last few sessions? Especially considering there will be constant war and the defense industry has big time lobbyists......
I was thinking of picking up some shares here. The technology is very interesting. Just wondering about the share structure......A/S is unlimited???? Has anyone seen any evidence of dilution over the years??? I would hate to jump in and then see them dilute. TIA
Whats with the Stop sign/Warning?
https://www.otcmarkets.com/stock/EPGL/overview
That was 2015. Looks like epgl fell a little short of .88 or even $1+. That two year AT&T agreement would have expired if my math is correct. (2015 + 2 years = 2017). Oh well. At least InWith has a new website as of March 15 and it’s worth $50 a share with the conversion so they say. But PwC is watching with justice backing them. What possibly could go wrong? All is well in iPo land.
I know I know.....we will "know more" after the conversion. Or there will be "no more" after the conversion. But wait, there is justice. IMO.
Perhaps you should work for inwith. You at least give an explanation.
Inwith corp already blossomed into another company? Maybe they set the value of inwith shares for this new newer company at $500/share? Details AFTER the conversion right? At least the new website is up and running and looking good right? IMO. #joke???